{
  "trial_id": "NCT01484873",
  "trial_group": "obesity",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, Gender, BMI, History of craniopharyngioma or other hypothalamic lesion, Time since treatment completion, HgbA1C levels, Renal function, History of gall stones, History of pancreatitis, History of alcoholism, Family history of medullary carcinoma of the thyroid, Family history of MEN type 2, History of gastroparesis, History of allergic reactions to medications, Comorbidities, Current medications, Pregnancy status, History of severe hypoglycemia.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Gender",
          "Gender"
        ],
        [
          "BMI",
          "BMI"
        ],
        [
          "Hemoglobin A1C",
          "HgbA1C levels"
        ],
        [
          "Hypothalamic injury",
          "History of craniopharyngioma or other hypothalamic lesion"
        ],
        [
          "Years since diagnosis",
          "Time since treatment completion"
        ]
      ],
      "remaining_reference_features": [
        "Race",
        "Body fat",
        "Homeostasis model assessment of insulin resistance (HOMA)",
        "uantitative insulin-resistivity check index (QUICKI)",
        "Childhood onset",
        "Hormone deficiencies"
      ],
      "remaining_candidate_features": [
        "Renal function",
        "History of gall stones",
        "History of pancreatitis",
        "History of alcoholism",
        "Family history of medullary carcinoma of the thyroid",
        "Family history of MEN type 2",
        "History of gastroparesis",
        "History of allergic reactions to medications",
        "Comorbidities",
        "Current medications",
        "Pregnancy status",
        "History of severe hypoglycemia"
      ]
    },
    "processed-gen-response": "Age, Gender, BMI, History of craniopharyngioma or other hypothalamic lesion, Time since treatment completion, HgbA1C levels, Renal function, History of gall stones, History of pancreatitis, History of alcoholism, Family history of medullary carcinoma of the thyroid, Family history of MEN type 2, History of gastroparesis, History of allergic reactions to medications, Comorbidities, Current medications, Pregnancy status, History of severe hypoglycemia."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Sex, BMI, History of craniopharyngioma or other hypothalamic lesion, Time since treatment completion, HbA1c, Renal function, History of gall stones, History of pancreatitis, History of alcoholism, Family history of medullary carcinoma of the thyroid, Family history of MEN type 2, History of gastroparesis, History of allergic reactions to medications, Use of diabetes medications, Use of weight loss drugs, Significant comorbidities, Use of warfarin, Pregnancy status, History of severe hypoglycemia",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Gender",
          "Sex"
        ],
        [
          "BMI",
          "BMI"
        ],
        [
          "Hemoglobin A1C",
          "HbA1c"
        ],
        [
          "Hypothalamic injury",
          "History of craniopharyngioma or other hypothalamic lesion"
        ],
        [
          "Years since diagnosis",
          "Time since treatment completion"
        ]
      ],
      "remaining_reference_features": [
        "Race",
        "Body fat",
        "Homeostasis model assessment of insulin resistance (HOMA)",
        "uantitative insulin-resistivity check index (QUICKI)",
        "Childhood onset",
        "Hormone deficiencies"
      ],
      "remaining_candidate_features": [
        "Renal function",
        "History of gall stones",
        "History of pancreatitis",
        "History of alcoholism",
        "Family history of medullary carcinoma of the thyroid",
        "Family history of MEN type 2",
        "History of gastroparesis",
        "History of allergic reactions to medications",
        "Use of diabetes medications",
        "Use of weight loss drugs",
        "Significant comorbidities",
        "Use of warfarin",
        "Pregnancy status",
        "History of severe hypoglycemia"
      ]
    },
    "processed-gen-response": "Age, Sex, BMI, History of craniopharyngioma or other hypothalamic lesion, Time since treatment completion, HbA1c, Renal function, History of gall stones, History of pancreatitis, History of alcoholism, Family history of medullary carcinoma of the thyroid, Family history of MEN type 2, History of gastroparesis, History of allergic reactions to medications, Use of diabetes medications, Use of weight loss drugs, Significant comorbidities, Use of warfarin, Pregnancy status, History of severe hypoglycemia"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Sex, BMI, History of craniopharyngioma or other brain lesion, Post-treatment duration, HbA1c, Menopausal status, Use of birth control, History of diabetes medications, History of weight loss drugs, Renal function, History of gallstones, History of pancreatitis, History of alcoholism, Family history of medullary carcinoma of the thyroid or MEN type 2, History of gastroparesis, History of allergic reaction to exenatide, Comorbidities other than pituitary deficiencies, Warfarin use, Pregnancy or lactation status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Gender",
          "Sex"
        ],
        [
          "BMI",
          "BMI"
        ],
        [
          "Hemoglobin A1C",
          "HbA1c"
        ],
        [
          "Hypothalamic injury",
          "History of craniopharyngioma or other brain lesion"
        ],
        [
          "Years since diagnosis",
          "Post-treatment duration"
        ],
        [
          "Hormone deficiencies",
          "Comorbidities other than pituitary deficiencies"
        ]
      ],
      "remaining_reference_features": [
        "Race",
        "Body fat",
        "Homeostasis model assessment of insulin resistance (HOMA)",
        "uantitative insulin-resistivity check index (QUICKI)",
        "Childhood onset"
      ],
      "remaining_candidate_features": [
        "Menopausal status",
        "Use of birth control",
        "History of diabetes medications",
        "History of weight loss drugs",
        "Renal function",
        "History of gallstones",
        "History of pancreatitis",
        "History of alcoholism",
        "Family history of medullary carcinoma of the thyroid or MEN type 2",
        "History of gastroparesis",
        "History of allergic reaction to exenatide",
        "Warfarin use",
        "Pregnancy or lactation status"
      ]
    },
    "processed-gen-response": "Age, Sex, BMI, History of craniopharyngioma or other brain lesion, Post-treatment duration, HbA1c, Menopausal status, Use of birth control, History of diabetes medications, History of weight loss drugs, Renal function, History of gallstones, History of pancreatitis, History of alcoholism, Family history of medullary carcinoma of the thyroid or MEN type 2, History of gastroparesis, History of allergic reaction to exenatide, Comorbidities other than pituitary deficiencies, Warfarin use, Pregnancy or lactation status."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, BMI, history of craniopharyngioma or other brain lesion, time since treatment, HgbA1C, use of metformin, history of diabetes, history of weight loss attempts, history of gallstones, history of pancreatitis, history of alcoholism, family history of medullary carcinoma of the thyroid or MEN type 2, history of gastroparesis, history of allergic reactions, presence of pituitary deficiencies, use of warfarin, history of severe hypoglycemia.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Gender",
          "sex"
        ],
        [
          "BMI",
          "BMI"
        ],
        [
          "Hemoglobin A1C",
          "HgbA1C"
        ],
        [
          "Hypothalamic injury",
          "history of craniopharyngioma or other brain lesion"
        ],
        [
          "Years since diagnosis",
          "time since treatment"
        ],
        [
          "Hormone deficiencies",
          "presence of pituitary deficiencies"
        ]
      ],
      "remaining_reference_features": [
        "Race",
        "Body fat",
        "Homeostasis model assessment of insulin resistance (HOMA)",
        "uantitative insulin-resistivity check index (QUICKI)",
        "Childhood onset"
      ],
      "remaining_candidate_features": [
        "use of metformin",
        "history of diabetes",
        "history of weight loss attempts",
        "history of gallstones",
        "history of pancreatitis",
        "history of alcoholism",
        "family history of medullary carcinoma of the thyroid or MEN type 2",
        "history of gastroparesis",
        "history of allergic reactions",
        "use of warfarin",
        "history of severe hypoglycemia"
      ]
    },
    "processed-gen-response": "Age, sex, BMI, history of craniopharyngioma or other brain lesion, time since treatment, HgbA1C, use of metformin, history of diabetes, history of weight loss attempts, history of gallstones, history of pancreatitis, history of alcoholism, family history of medullary carcinoma of the thyroid or MEN type 2, history of gastroparesis, history of allergic reactions, presence of pituitary deficiencies, use of warfarin, history of severe hypoglycemia."
  }
}